(Q43995413)

English

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

brain metastasis

1 reference

based on heuristic

inferred from title

Thomas Kurt Eigentler

1

1 reference

Europe PubMed Central

28 November 2017

Dirk Schadendorf

11

object named as

Dirk Schadendorf

1 reference

Europe PubMed Central

28 November 2017

9

object named as

Oliver Koelbl

1 reference

Europe PubMed Central

28 November 2017

author name string

Adina Figl

2

1 reference

Europe PubMed Central

28 November 2017

Dietmar Krex

3

1 reference

Europe PubMed Central

28 November 2017

Peter Mohr

4

1 reference

Europe PubMed Central

28 November 2017

Cornelia Mauch

5

1 reference

Europe PubMed Central

28 November 2017

Knut Rass

6

1 reference

Europe PubMed Central

28 November 2017

Azize Bostroem

7

1 reference

Europe PubMed Central

28 November 2017

Oliver Heese

8

1 reference

Europe PubMed Central

28 November 2017

Claus Garbe

10

1 reference

Europe PubMed Central

28 November 2017

Dermatologic Cooperative Oncology Group and the National Interdisciplinary Working Group on Melanoma

12

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

8 November 2010

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

117

1 reference

Europe PubMed Central

28 November 2017

8

1 reference

Europe PubMed Central

28 November 2017

1697-1703

1 reference

Europe PubMed Central

28 November 2017

Metastatic pattern of malignant melanoma. A study of 216 autopsy cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

The treatment of brain metastases from malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Treatment of brain metastases from melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Current management of brain metastases, with a focus on systemic options

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Determinants of outcome in melanoma patients with cerebral metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Determinants of survival in patients with brain metastases from cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Radiosurgery and whole-brain radiation therapy for brain metastases: either or both as the optimal treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

21 January 2018

Treatment options for limited or symptomatic metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

7 January 2021

based on heuristic

inferred from DOI database lookup

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: Radiation Therapy Oncology Group Brain Metastases Study I and II

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25631

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25631

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43995413&oldid=2105421235"